ArticleBMC pediatrics2026
Impact of birth weight on long-term growth and development in children: evidence from a nationwide cohort study.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundBirth weight (BW) is a well-established key marker of early health, but its long-term influence on growth and development in the general pediatric population remains uncertain. This study aimed to assess the longitudinal association of BW on growth and neurodevelopment from infancy to six years of age using nationwide population-based data from Korea.
methodsWe analyzed data from 3,033,843 children born between 2013 and 2020 who participated in the Korean National Health Insurance Service infant and child health screening program. Participants were stratified into five birth weight categories (< 1,000; 1,000–1,499; 1,500–2,499; 2,500–3,999; and ≥ 4,000 g) and followed across seven screening rounds. Growth and neurodevelopmental outcomes were assessed using standardized anthropometric measures and the Korean Developmental Screening Test for Infants and Children (K-DST), respectively. Longitudinal patterns were examined at each round, and the primary analysis focused on outcomes at 30–36 months using multivariable logistic regression to identify risks for growth failure and screening-positive developmental delay.
resultsAcross screening rounds, children with lower BWs, especially those under 1,500 g, showed consistently lower growth percentiles and higher rates of K-DST screen-positive results. At 30–36 months, infants with BW < 1,000 g had substantially higher odds of growth failure across all three anthropometric measures (height, weight, and head circumference) (aOR range 25.2–43.1 vs. ≥ 2,500 g; all p < 0.001) and of screening positive for developmental delay (K-DST < − 2 SD) (aOR 3.62, 95% CI 3.12–4.21, p < 0.001). Male sex and neonatal morbidities such as bronchopulmonary dysplasia, periventricular leukomalacia, and hypoxic-ischemic encephalopathy were also associated with growth failure and developmental delay at 30–36 months. Disparities in growth and development persisted across screening rounds, particularly among the < 1,500 g BW groups.
conclusionsLower BW, particularly < 1,500 g, was associated with higher odds of growth failure and screening-positive developmental risk at 30–36 months, with disparities in growth and development persisting through early childhood.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.